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Abstract
Background: A major biomarker for liver fibrosis is transglutaminase which catalyzes cross-linking
of epsilon-amines and alpha-glutamyl residues among amino acids leading to fibrosis. Fructus Piperis
Longi is a common herb used in Chinese medicine. The present study evaluates the role of the
ethanol extract of Fructus Piperis Longi in the modulation of liver function in liver fibrosis.
Methods: Plf extract (50 mg/kg) was force-fed to rats every other day 7 days before administration
of thioacetamide and/or gamma irradiation. Thioacetamid 200 mg/kg was intraperitoneally
administered to rats twice per week for four weeks. Rats were gamma irradiated (2 Gy/week up
to a total dose of 8 Gy). Administration of Plf ext was extended during thioacetamid and/or
irradiation treatment. Animals were sacrificed. Biochemical parameters in homogenised liver were
tested.
Results: A significant increase in transglutaminase activity and collagen content was recorded in
the liver of thioacetamid-treated and/or irradiated rats. Significant increases in lipid peroxides, lipid
hydroperoxides and conjugated dienes associated to significant decreases of reduced glutathione
content, superoxide dismutase and catalase activities were also recorded. Administration of Plf ext
treatment reduced the severity of liver fibrosis and oxidative damage which was substantiated by
amelioration of liver function detected by a decrease in serum aspartate aminotransaminase,
alanine aminotransferase, alkaline phosphatase, gamma glutamyltransferase activities and bilirubin
(total, direct and indirect) content.
Conclusion: Treatment of the ethanolic extract of Fructus Piperis Longi ameliorated the increase
of the activity of tTG enzyme and enhanced antioxidant activities in fibrotic liver.
Background
Fibrosis of the liver is a state of complicated end stage
alteration of structure and function due to different aetiol-
ogies. Fibrosis is a consequence of different prevalent
mechanisms according to the diverse causes of parenchy-
mal damage. Fibrosis caused by chronic viral infection is
initially concentrated within and around the portal tract,
while fibrosis secondary to toxic/metabolic damage is
located mainly in the centrolobular areas [1].
Oxidative stress, characterized by the overproduction of
reactive oxygen species (ROS), which overwhelm the lev-
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factor of a number of human diseases and was reported to
cause tissue damage [2]. ROS can react with cellular mac-
romolecules such as nucleic acids, polyunsaturated fatty
acids in cellular membranes and sulfhydryl bonds in pro-
teins to cause mutagenesis, carcinogenesis and cell death.
Thioacetamide (TAA, CH3-C[S] NH2), a known fungicide
used to control the decay of fruits [3] was shown to be S-
oxidized at the thioamide group to TAA sulfoxide (CH3-
C[SO] NH2) and subsequently di-Soxide (CH3-C[SO2]
NH2) in the liver. The reactive intermediates in this path-
way covalently bind to hepatic macromolecules and even-
tually cause liver injury [4,5], whereby free radical-
mediated lipid peroxidation contributes to the develop-
ment of TAA induced liver fibrosis [6,7]. Prolonged
administration of TAA causes hyperplastic liver nodules,
liver cell adenomas and hepatocarcinomas. The free radi-
cals produced during TAA metabolism interfere with
ribosomal activity, thereby hindering protein synthesis
[8]. The biochemical and morphological changes
observed in TAA-induced rat liver injury resemble to a
large extent human liver disease and could serve as a suit-
able model for studying the causes of human liver fibrosis
and cirrhosis [9].
Tissue fibrosis is associated with the increase of the tTG
activity and accumulation of ECM [10]. In liver fibrosis
induced in rats by carbon tetrachloride (CCl4) and in
human patients with an acute liver disease, Mirza et al.
[11] found a dramatic rise in tissue transglutaminases
(tTG) activity. The enzyme catalyzes the specific cross-
linking of ε-amines and α-glutamyl residues among
amino acids [12]. This activity leads to the cross-linking of
extracellular matrix (ECM) proteins thereby increasing the
deposition [13] of such proteins and their resistance to
proteolytic enzymes, which leads to tissue fibrosis
[14,15]. Several studies specifically described the role of
tTG in cross-linking of fibronectin, osteonectin, osteopon-
tin, laminin and other extracellular matrix components
[12].
The pathogenesis of liver fibrosis is not clear; however, it
was suggested that an increase of ROS coupled with a
decrease in body antioxidant system activity play an
important role in the pathological changes, particularly in
the cases of radiation exposure and liver toxicity [16].
Radiation exposure may cause disruption of normal cell
membranes as a result of direct interaction of radiation
with cellular membranes or through the action of free rad-
icals produced by radiation [17].
Several endogenous protective mechanisms may limit
ROS and the damage caused by them [18]. However, this
protection may be insufficient. When the formation of
ROS is excessive, additional protective mechanisms of die-
tary, antioxidants may help maintain liver functions. Sev-
eral natural antioxidants were proposed to prevent and
treat hepatopathies induced by oxidative stress [19]. Rich
in flavonoids, Fructus Piperis Longi (Bibo, long pepper) is
used in Chinese medicine to treat various conditions such
as jaundice and allergy [20]. It has been demonstrated to
be anti-tussive, anti-asthmatic, anti-allergic, anti-tubercu-
lar, antipyretic, hypotensive, hypoglycemic, antihelmen-
tic and coronary vasodilatory [21]. The aim of the present
study is to investigate the hepatoprotective activity of Fruc-
tus Piperis Longi against liver fibrosis.
Methods
Materials and instrument
Fructus Piperis Longi was obtained from the local market.
All chemicals and reagents used in the experiment were of
analytical grade and purchased from either Merck (Ger-
many) or Sigma Aldrich Chemie (Germany). Assay kits for
testing alkaline phosphatase (ALP), alanine aminotrans-
ferase (ALT), aspartate aminotransaminase (AST), gamma
glutamyltransferase (GGT), bilirubin and total protein
were supplied by Diamond Diagnostics (Egypt).
Instrument included electric digital balance (Shimadzu,
Type Ay 220, Japan), pH meter (Jenway, UK), homoge-
nizer (Glas-col, TERRE HAUT, USA), cooling centrifuge
(Memmert, Model K23, Germany), centrifuge (Janetzki,
Model T30, Germany), shaker incubator (Lab-Line Instru-
ments, USA) and spectrophotometer (Helios, UV/Visible,
UK).
Experimental animals
All animal treatment procedures conformed to the
National Institutes of Health (NIH) guidelines [22].
Sprague Dawley male albino rats (170–220 g) were used
in this study. Animals were obtained from the National
Centre for Radiation Research and Technology (NCCRT),
Cairo, Egypt. The animals were housed in cages and main-
tained under standard conditions of ventilation, tempera-
ture and humidity. Animals received standard food pellets
and water ad libitum.
Gamma irradiation procedure
Irradiation of animals was carried out at the National
Centre for Radiation Research and Technology (NCRRT)
in Cairo, Egypt, with a Gamma cell-40 (Cesium-137 irra-
diation units, Canada). The irradiation dose rate was 0.61
Gy/min. Animals (whole body) were exposed to 2 Gy per
week at a total dose of 8 Gy, one day after TAA adminis-
tration.
Induction of liver fibrosis
Liver fibrosis was induced by intraperitoneal administra-
tion of 200 mg/kg TAA twice per week for four weeks
according to El Borai et al. [23].Page 2 of 8
(page number not for citation purposes)
Chinese Medicine 2009, 4:2 http://www.cmjournal.org/content/4/1/2Preparation of Fructus Piperis Longi extract
The ethanolic extract of Fructus Piperis Longi was prepared
according to Christina et al. [21]. Fructus Piperis Longi was
obtained from the local market and was dried and pow-
dered. About 500 g of dry powder was extracted with 5L of
ethanol at 60–70°C for 72 hours by continuous hot per-
colation with a Soxhlet apparatus. The ethanolic extract
was then filtered and concentrated by vacuum distillation
to dry. The yield for 500 g was 37 g. This dried extract was
then stored at 4°C until use. Rats were force-fed 50 mg/kg
of distilled water per day for five weeks starting from seven
days before TAA administration.
Animal groups
The experimental animals were divided into eight groups
(n = 6), namely (1) Control: healthy animals received dis-
tilled water; (2) Plf ext: animals received Fructus Piperis
Longi extract; (3) TAA: animals were injected with TAA; (4)
Plf ext + TAA: animals received Fructus Piperis Longi extract
and were injected with TAA; (5) γ irradiation: animals
were exposed to γ irradiation; (6) Plf ext + γ irradiation:
animals received Fructus Piperis Longi extract and were
exposed to γ irradiation; (7) TAA + γ irradiation: animals
were injected with TAA and exposed to γ irradiation and
(8) Plf ext + TAA + γ irradiation: animals received Fructus
Piperis Longi extract and were injected with TAA and
exposed to γ irradiation.
Rats of all groups received the last irradiation exposure on
the day before overnight fasting and sacrifice. Blood sam-
ples were collected by heart puncture. Plasma of each
blood sample was separated and kept frozen for biochem-
ical assays. Liver samples were kept at -80°C until bio-
chemical assays. Liver tissue homogenate (10% w/v) in
phosphate-buffered-saline (0.02 M sodium phosphate
buffer with 0.15 M sodium chloride, pH7.4) was prepared
with a portion of liver homogenized in a glass tissue
homogenizer with a Teflon pestle.
Biochemical assays
Tissue transglutaminase (tTG) activity in 100 μl liver
homogenate was determined according to the direct spec-
trophotometric method by De Macedo et al. [24]. Total
protein content in liver tissue was determined according
to the method by Henry [25] to calculate the specific
enzyme activity of tTG in the liver. Liver collagen content
was determined according to Woessner [26].
Reduced glutathione concentration (GSH) in liver was
determined according to Beutler et al. [27]. Superoxide
dismutase (SOD) activity in liver was measured according
to Minami and Yoshikawa [28]. The colorimetric assay for
liver catalase activity (Cat) was carried out according to
Sinha [29]. Lipid peroxides (LP) indicated by the forma-
tion of malondialdehyde (MDA) was assessed in liver
homogenates according to Yoshioka et al. [30]. Lipid
hydroperoxides (LHP) in liver was determined according
to the Fox method described by Jiang et al. [31]. The levels
of conjugated dienes (CD) in liver were measured accord-
ing to Rechnagel and Gglende and Nowak et al. [32,33].
Plasma ALP activity was determined according to Teitz
[34]. Activities of ALT and AST were determined colori-
metrically according to Reitman and Frankel [35]. Plasma
gamma GGT activity was measured kinetically according
to Szasz [36]. Plasma bilirubin (total, direct and indirect)
contents were determined according to Perry et al. [37].
Statistical analysis
The SPSS (version 10) was used in data analysis. Data
were analyzed with one-way analysis of variance
(ANOVA) followed by a post hoc test (LSD alpha) for mul-
tiple comparisons. The data were expressed as mean ±
standard deviation (SD). P values < 0.05 were considered
to be statistically significant.
Results
Administration of Fructus Piperis Longi ethanol extract (Plf
ext) to rats, by force-feeding, for a period of five weeks, did
not show significant changes in all the studied parame-
ters, indicating that the extract did not affect the liver func-
tions (Tables 1, 2, 3, 4, 5).
As shown in Table 1, TAA significantly increased (P =
0.0001) liver collagen content and tTG activity. Irradiated
rats showed significantly increased liver collagen content
(P = 0.019) and tTG activity (P = 0.0001). In the TAA +
irradiation group, significant increases (P = 0.0001) in
liver collagen content and tTG activity were observed.
Treatment of Plf ext significantly ameliorated (P = 0.0001,
no significance, 0.0001, 0.0001, 0.0001 and 0.0001
respectively) the increase of collagen content and tTG
activities in the rats that received TAA or γ-irradiation or
both (Table 1).
TAA induced significant decreases (P = 0.0001) in liver
GSH content, SOD and Cat activities (Table 2), which
were parallel to significant increases in LP (P = 0.0001),
LPH (P = 0.003) and CD (P = 0.0001) content (Table 3).
Irradiated rats showed significant decreases (P = 0.0001)
in liver GSH content and Cat activity in association with
significant increases in LP (P = 0.0001), LPH (P = 0.008)
and CD (P = 0.002) content (Tables 2 and 3). In the TAA
+ irradiation group, significant decreases (P = 0.0001) in
liver GSH content, SOD and Cat activities in association
with significant increases in LP (P = 0.0001), LPH (P =
0.001) and CD (P = 0.0001) content were observed. Treat-
ment of Plf ext significantly reduced (P = 0.0001) oxida-
tive stress in the rats that received TAA or γ-irradiation or
both.Page 3 of 8
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Table 2: SOD and Cat activities and GSH content in liver tissue homogenates of rats under different treatment conditions
Groups SOD (μg/g wet tissue) Cat (μmol/g wet tissue) GSH (mg/g wet tissue)
Control 12.06 ± 0.701 119.36 ± 9.799 24.75 ± 1.035
Plf ext 12.38 ± 0.499 119.37 ± 5.334 25.06 ± 0.752
TAA 10.79 ± 0.054 101.40 ± 3.561 21.02 ± 0.699
a P = 0.0001 P = 0.0001 P = 0.0001
Plf ext+TAA 11.84 ± 0.398 118.89 ± 4.522 23.26 ± 0.586
a NS NS P = 0.0001
b NS P = 0.001 P = 0.0001
γ radiation 11.52 ± 0.151 99.63 ± 9.279 20.60 ± 0.793
a NS P = 0.0001 P = 0.0001
Plf ext+γ radiation 11.88 ± 0.031 117.32 ± 9.122 23.11 ± 0.867
a NS NS P = 0.0001
c NS P = 0.001 P = 0.0001
TAA+γ radiation 10.64 ± 0.316 91.01 ± 6.793 19.86 ± 0.263
a P = 0.0001 P = 0.0001 P = 0.0001
b NS P = 0.041 P = 0.009
c P = 0.002 NS NS
Plf ext+TAA+γ radiation 11.82 ± 0.880 111.82 ± 14.453 22.80 ± 0.594
a P = 0.001 NS P = 0.0001
b P = 0.001 P = 0.041 P = 0.0001
c NS P = 0.018 P = 0.0001
d P = 0.0001 P = 0.0001 P = 0.0001
Each value represents mean ± SD of 6 determinations.
a: significance over control group
b: significance over TAA group
c: significance over γ radiation group
d: significance over TAA+γ radiation group
NS: no significance
Table 1: Transglutaminase (tTG) activity and collagen content in liver tissue homogenates of rats under different treatment 
conditions
Groups tTG (anilide/umol/mg protein/min) Collagen (mg/g wet tissue)
Control 1.26 ± 0.182 3.96 ± 0.346
Plf ext 1.32 ± 0.111 4.03 ± 0.221
TAA 2.87 ± 0.166 6.14 ± 0.318
a P = 0.0001 P = 0.0001
Plf ext+TAA 1.58 ± 0.085 4.60 ± 0.163
a P = 0.007 P = 0.013
b P = 0.0001 P = 0.0001
γ radiation 2.26 ± 0.070 4.56 ± 0.253
a P = 0.0001 P = 0.019
Plf ext+γ radiation 1.37 ± 0.082 4.20 ± 0.499
a NS NS
c P = 0.0001 NS
TAA+γ radiation 3.49 ± 0.185 6.77 ± 0.075
a P = 0.0001 P = 0.0001
b P = 0.0001 P = 0.015
c P = 0.0001 P = 0.0001
Plf ext+TAA+γ radiation 1.76 ± 0.065 5.13 ± 0.125
a P = 0.0001 P = 0.0001
b P = 0.0001 P = 0.0001
c P = 0.0001 P = 0.023
d P = 0.0001 P = 0.0001
Each value represents mean ± SD of 6 determinations.
a: significance over control group
b: significance over TAA group
c: significance over γ radiation group
d: significance over TAA+γ radiation group
NS: no significance
Chinese Medicine 2009, 4:2 http://www.cmjournal.org/content/4/1/2Significant increases (P = 0.0001) of plasma ALT, AST,
ALP and GGT activities were observed in rats that received
TAA or γ-irradiation or both. Treatment of Plf ext amelio-
rated (P = 0.0001) these increases (Table 4).
Significant increases (P = 0.0001) in the content of total,
direct and indirect bilirubin were observed in the rats that
received TAA or γ-irradiation or both. Treatment of Plf ext
ameliorated (P = 0.0001) these increases (Table 5).
Figure 1 shows a significant increase in the liver weight of
the rats that received TAA or γ-irradiation or both. Admin-
istration of Plf ext did not significantly ameliorate liver
weight.
Discussion
In the present study, parameters of liver fibrosis induced
by TAA with or without radiation exposure were shown as
an increase of liver weight, significant increases in liver
tTG activity and collagen content associated with signifi-
cant decreases in GSH content, SOD and Cat activities and
increases in LP, LHP and CD content. Hepatic damage was
indicated by significant increases of serum AST, ALT, ALP
activities and bilirubin content.
The increase in tTG activity may be attributed to the
increased binding of the nuclear factor-kappaB (NF-κB) to
the NF-κB motif of the tTG promoter, where tTG gene
expression increases during hepatic injury and fibrosis
[38]. The concomitant increase of both hepatic collagen
and tTG activity may be explained by the dual effect
exerted by the NF-κB, which is induced by oxidative stress
Rats' liver weight under various treatment conditionsFigure 1
Rats' liver weight under various treatment condi-
tions. Each value represents the mean ± SD of 6 determina-
tions. a: significance of treatment over control P = 0.0001, 
0.021, 0.0001 and 0.001 respectively. c: significance of treat-
ment over γ irradiation group P = 0.003 and 0.030 respec-
tively.
Table 3: Lipid peroxides (LP), lipid hydroperoxide (LHP) and conjugated diene (CD) in liver tissue homogenates of rats under different 
treatment conditions
Groups LP (μg/g tissue) LHP (μM) CD (Abs234/g tissue)
Control 108.27 ± 7.246 17.81 ± 0.841 2.20 ± 0.091
Plf ext 114.72 ± 5.170 17.90 ± 0.759 2.20 ± 0.068
TAA 169.04 ± 16.914 21.64 ± 1.995 3.14 ± 0.042
a P = 0.0001 P = 0.003 P = 0.0001
Plf ext+TAA 127.47 ± 2.480 17.79 ± 2.949 2.30 ± 0.200
a P = 0.003 NS NS
b P = 0.0001 P = 0.003 P = 0.0001
γ radiation 135.54 ± 13.191 20.91 ± 0.833 2.54 ± 0.191
a P = 0.0001 P = 0.008 P = 0.002
Plf ext+γ radiation 123.98 ± 4.606 17.52 ± 2.553 2.24 ± 0.043
a P = 0.012 NS NS
c NS P = 0.008 P = 0.006
TAA+γ radiation 182.93 ± 9.560 21.92 ± 1.958 3.20 ± 0.015
a P = 0.0001 P = 0.001 P = 0.0001
b P = 0.025 NS NS
c P = 0.0001 NS P = 0.0001
Plf ext+TAA+γ radiation 142.04 ± 14.092 17.88 ± 2.247 2.47 ± 0.116
a P = 0.0001 NS P = 0.011
b P = 0.0001 P = 0.003 P = 0.0001
c NS P = 0.01 NS
d P = 0.0001 P = 0.001 P = 0.0001
Each value represents mean ± SD of 6 determinations.
a: significance over control group
b: significance over TAA group
c: significance over γ radiation group
d: significance over TAA+γ radiation group
NS: no significancePage 5 of 8
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and fibrosis may involve other factors such as the factor-
beta (TGF-β), major fibrogenic growth factors, where tTG
activates the latent TGF-μ1, which in turn leads to de novo
synthesis of tTG [40]. The increase of tTG activity may also
be a consequence of GSH depletion and mitochondrial
dysfunction [41].
The depletion in GSH content may be due to the oxidation
of sulfhydryl group and diminished activity of glutathione
reductase [42]. The significant decrease in the activity of
antioxidant enzymes may be caused by cell membrane
damage and alterations in dynamic permeability of mem-
branes due to peroxidation, followed by the release of intra-
cellular enzymes to the blood stream [43]. In addition, an
excess of •OH causes oxidative damage to enzymes, result-
ing in the modification of their activities [43,44]. The
marked increase in MDA levels is likely to be a result of the
inactivation of scavenger enzymes induced by ROS [44-46].
According to Ueda et al. [47], the generation of lipid perox-
ide and its appearance in the animal's liver may be a result
of a chain of reactions or may be initiated by an indirect
mechanism that enables the escape from anti-oxidation.
Fructus Piperis Longi has recently been proposed as a chem-
opreventive agent for its antioxidant activities [48,49]. The
present study showed that treatment of Plf ext significantly
reduced liver fibrosis as evidenced by significant decreases
of tTG activity and collagen content, with concomitant
enhancement of the antioxidant status and improvement
of liver functions. The results are consistent with other
reports on the role of polyphenols against oxidative stress
[39] because Plf ext is rich in polyphenols [50] which may
up-regulate the antioxidant [51-53], thereby decreasing the
free radical-induced lipid peroxidation [51].
The increased resistance of liver tissue against liver fibrosis
and oxidative stress after treatment was shown by the sig-
nificant decreases in serum ALT, ALP and AST activities
and bilirubin content. The results are consistent with a
previous study which demonstrated that the ethanolic
extract of Fructus Piperis Longi possessed hepatoprotective
activity lowering serum enzymes ALT and AST [54]. Fur-
ther studies NF-κB, tTG gene expression and TGF-B would
help elucidate the mechanism of action
Conclusion
Treatment of the ethanolic extract of Fructus Piperis Longi
ameliorated the increase of the activity of tTG enzyme and
enhanced the antioxidant activities in fibrotic liver.
Abbreviations
tTG: transglutaminase; Plf ext: Fructus Piperis Longi ethanol
extract; TAA: thioacetamide; LP: lipid peroxides; LHP:
Table 4: ALT, AST, ALP and GGT activities in plasma of rats under different treatment conditions
Groups ALT (U/l) AST (U/l) ALP (U/l) GGT (U/I)
Control 15.54 ± 1.987 8.00 ± 0.503 50.11 ± 1.241 1.00 ± 0.00
Plf ext 15.44 ± 2.001 8.18 ± 0.804 49.36 ± 1.017 1.08 ± 0.144
TAA 23.58 ± 1.282 16.04 ± 3.380 94.35 ± 2.431 4.66 ± 0.212
a P = 0.0001 P = 0.0001 P = 0.0001 P = 0.0001
Plf ext+TAA 17.03 ± 1.92 9.29 ± 0.419 54.24 ± 1.417 2.30 ± 0.282
a NS NS P = 0.0001 P = 0.0001
b P = 0.0001 P = 0.0001 P = 0.0001 P = 0.0001
γ radiation 19.91 ± 1.371 14.37 ± 0.567 88.00 ± 1.763 2.62 ± 0.247
a P = 0.0001 P = 0.0001 P = 0.0001 P = 0.0001
Plf ext+γ radiation 17.17 ± 1.899 9.26 ± 0.585 51.98 ± 1.592 1.43 ± 0.087
a NS NS NS P = 0.036
c P = 0.006 P = 0.0001 P = 0.0001 P = 0.0001
TAA+γ radiation 24.60 ± 1.268 21.20 ± 0.560 104.40 ± 3.241 5.78 ± 0.358
a P = 0.0001 P = 0.0001 P = 0.0001 P = 0.0001
b NS P = 0.0001 P = 0.0001 P = 0.0001
c P = 0.0001 P = 0.0001 P = 0.0001 P = 0.0001
Plf ext+TAA+γ radiation 19.85 ± 0.813 12.20 ± 1.344 55.99 ± 2.794 2.71 ± 0.276
a P = 0.0001 P = 0.0001 P = 0.0001 P = 0.0001
b P = 0.0001 P = 0.0001 P = 0.0001 P = 0.0001
c NS P = 0.011 P = 0.0001 NS
d P = 0.0001 P = 0.0001 P = 0.0001 P = 0.0001
Each value represents mean ± SD of 6 determinations.
a: significance over control group
b: significance over TAA group
c: significance over γ radiation group
d: significance over TAA+γ radiation group
NS: no significancePage 6 of 8
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reduced glutathione; SOD: superoxide dismutase; Cat:
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a P = 0.049 P = 0.0001 NS
b P = 0.0001 P = 0.0001 P = 0.0001
γ radiation 1.307 ± 0.071 0.199 ± 0.014 1.103 ± 0.074
a P = 0.0001 P = 0.0001 P = 0.0001
Plf ext+γ radiation 0.923 ± 0.033 0.162 ± 0.009 0.761 ± 0.030
a NS P = 0.020 NS
c P = 0.0001 P = 0.0001 P = 0.0001
TAA+γ radiation 3.137 ± 0.076 0.281 ± 0.008 2.856 ± 0.079
a P = 0.0001 P = 0.0001 P = 0.0001
b P = 0.0001 P = 0.0001 P = 0.0001
c P = 0.0001 P = 0.0001 P = 0.0001
Plf ext+TAA+γ radiation 1.310 ± 0.063 0.226 ± 0.005 1.084 ± 0.062
a P = 0.0001 P = 0.0001 P = 0.0001
b P = 0.0001 P = 0.0001 P = 0.0001
c NS P = 0.0001 NS
d P = 0.0001 P = 0.0001 P = 0.009
Each value represents mean ± SD of 6 determinations.
a: significance over control group
b: significance over TAA group
c: significance over γ radiation group
d: significance over TAA+γ radiation group
NS: no significancePage 7 of 8
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